Shire's acquisition of Viropharma last year helped its sales and earnings rocket in 2014, although chief executive Flemming Ornskov said growth in 2015 will be slower. Full-year sales grew 23 per ...
Glenn Tillotson is a full-time employee of ViroPharma Incorporated, PA, USA. Alan Tice has received income for research and consulting from Replidyne, Pfizer and Astellas. This work has been ...
Hosted on MSN17d
At Last, New Weapons in the Fight Against Colds and FluIt’s not like no one has tried. In the late ‘90s and early aughts, a now-defunct company, ViroPharma, developed an antiviral drug for common colds. Research suggested the drug, pleconaril ...
Shire, the London-listed pharmaceuticals group, has moved to bolster its rare disease treatment business with the $4.2bn acquisition of ViroPharma. Ireland-domiciled Shire will pay $50 a share in cash ...
Uncomplicated skin infections account for almost 200 million physician-office visits in the USA annually. Treating these infections is estimated to cost in excess of US$350 million each year. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback